Although ADAM9 has been shown to enhance pulmonary vascular remodeling in lung cancer via VEGFA, angiopoietin-2, and tissue plasminogen activator [19, 36], there is a paucity of literature linking ADAM9 to PH. This evidence concerns the gene VEGFA and lung cancer.